Research shows why immune checkpoint blockade impedes but does not stop glioblastoma progression – Medical Xpress

Like locking the door but opening windows, an immune checkpoint therapy temporarily slows glioblastoma (GBM) progression but fails to establish an effective anti-tumor microenvironment and appears to increase molecular interactions inhibiting long-term…

Click here to view the original article.